A first-in-human study to investigate safety and tolerability of SAR446959 in participants with osteoarthritis of the knee
This study is investigating a new medicine, SAR446959, for people who have osteoarthritis in their knee. This is a very early-stage study, meaning it's the very first time this particular medicine is being tried in humans. The main purpose is to carefully check if the medicine is safe for people to take and to see if they experience any uncomfortable side effects, or 'tolerability'. It's not about seeing if the medicine cures osteoarthritis yet, but rather gathering important information about its basic safety profile. Researchers will be looking closely at how the body reacts to the new treatment. Both men and women, aged 18 and older, who have knee osteoarthritis may be able to join this study.
Överblick
Vad handlar denna studie om?
This research is focused on osteoarthritis, a common condition that affects millions of people, especially in the knee. Osteoarthritis happens when the protective cartilage on the ends of your bones wears down over time, leading to pain, stiffness, and sometimes swelling. It can make everyday activities like walking or climbing stairs difficult.
Researchers are looking at a new medicine, which has the code name SAR446959. This is a "first-in-human" study, which means it's the very first time this specific medicine is being given to people. Before a new medicine can be used more widely, it has to go through several stages of testing. This initial stage is crucial for understanding how the human body reacts to the medicine.
The main goal of this particular study is to see if SAR446959 is safe for people to take and to understand its *tolerability*. Tolerability just means how well people cope with the medicine and if they experience any side effects. It's not about finding out if it will cure your knee pain yet, but about making sure it's safe enough to continue with further research. This careful first step is vital for developing new and effective treatments in the future.
Viktiga punkter
- This is a study of a new medicine (SAR446959) for knee osteoarthritis.
- It's the first time this medicine is being tried in humans.
- The main purpose is to check if the medicine is safe and how people tolerate it.
- Both men and women aged 18 and over with knee osteoarthritis may be eligible.
- Participation involves regular clinic visits for monitoring and assessments.
- Du kan dra dig ur studien när som helst.
Vem kan vara berättigad?
To join this study, you generally need to be an adult, aged 18 or older. Whether you are male or female, you could be considered for participation.
The study is specifically looking for people who have osteoarthritis in their knee. This means you would need to have been diagnosed with this condition by a doctor.
There will be other detailed criteria that the study team will need to check to make sure the study is right for you and that taking part would be safe. For example, they might need to know about any other health conditions you have, or any other medicines you are currently taking. This is all to ensure your safety throughout the study.
Kan denna studie passa dig?
Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.
- Är du 18 år eller äldre?
- Have you been diagnosed with osteoarthritis in your knee?
- Kan du delta i regelbundna klinikbesök?
- Are you willing to potentially receive a new, untested medicine?
- Are you comfortable with regular medical check-ups, including blood tests?
Vad innebär deltagande?
If you decide to take part in this study, you would first have a screening visit to check if you meet all the requirements. If you do, you would then receive the study medicine, SAR446959. Because this is a very early study, you would likely have regular visits to the clinic so the research team can carefully monitor your health and how you react to the medicine. These visits would involve various checks, such as blood tests, physical examinations, and possibly questionnaires about how you are feeling. The study team will explain exactly how many visits you would need, how long each visit might be, and the total length of time you would be involved in the study. All of this information would be provided before you agree to participate.
Potentiella risker och fördelar
Platser (1)
- —ObekräftadTyskland
Vanliga frågor
Vad är artros?
Osteoarthritis is a common condition where the smooth cartilage in your joints wears down over time, leading to pain, stiffness, and sometimes swelling, often in the knees.
What does 'first-in-human' mean?
It means this is the very first time this experimental medicine, SAR446959, is being given to people, after extensive testing in laboratories.
Will this medicine cure my knee pain?
The main goal of this study is to check for safety and how well people tolerate the medicine, not yet to see if it cures pain. That comes in later stages of research.
What kind of checks will I have during the study?
You would have regular check-ups, which might include blood tests, physical exams, and questions about how you are feeling, to carefully monitor your health.
Kan jag lämna studien om jag ändrar mig?
Yes, you have the right to leave the study at any time, for any reason, without your medical care being affected.
Hur du får reda på mer
Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.
Intresserad av att delta?
Diskussion
Gemenskapsdiskussion
Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.